Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections H Lv, NC Wu, OTY Tsang, M Yuan, RAPM Perera, WS Leung, RTY So, ... Cell reports 31 (9), 2020 | 451 | 2020 |
Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation MM Lamers, AZ Mykytyn, TI Breugem, Y Wang, DC Wu, S Riesebosch, ... Elife 10, e66815, 2021 | 92 | 2021 |
A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2 Y Wang, M Yuan, H Lv, J Peng, IA Wilson, NC Wu Immunity 55 (6), 1105-1117. e4, 2022 | 55 | 2022 |
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain TJC Tan, M Yuan, K Kuzelka, GC Padron, JR Beal, X Chen, Y Wang, ... Nature Communications 12 (1), 3815, 2021 | 52 | 2021 |
If llm is the wizard, then code is the wand: A survey on how code empowers large language models to serve as intelligent agents K Yang, J Liu, J Wu, C Yang, YR Fung, S Li, Z Huang, X Cao, X Wang, ... arXiv preprint arXiv:2401.00812, 2024 | 21 | 2024 |
Antigenic evolution of human influenza H3N2 neuraminidase is constrained by charge balancing Y Wang, R Lei, A Nourmohammad, NC Wu Elife 10, e72516, 2021 | 21 | 2021 |
The evolutionary potential of influenza A virus hemagglutinin is highly constrained by epistatic interactions with neuraminidase T Liu, Y Wang, TJC Tan, NC Wu, CB Brooke Cell host & microbe 30 (10), 1363-1369. e4, 2022 | 17* | 2022 |
Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2 M Yuan, Y Wang, H Lv, TJC Tan, IA Wilson, NC Wu Cell Reports 41 (7), 2022 | 15 | 2022 |
Mutational fitness landscape of human influenza H3N2 neuraminidase R Lei, AH Garcia, TJC Tan, QW Teo, Y Wang, X Zhang, S Luo, SK Nair, ... Cell reports 42 (1), 2023 | 12 | 2023 |
Egg-adaptive mutations of human influenza H3N2 virus are contingent on natural evolution W Liang, TJC Tan, Y Wang, H Lv, Y Sun, R Bruzzone, CKP Mok, NC Wu PLoS pathogens 18 (9), e1010875, 2022 | 11 | 2022 |
Human organoid systems reveal in vitro correlates of fitness for SARS-CoV-2 B.1.1.7 MM Lamers, TI Breugem, AZ Mykytyn, Y Wang, N Groen, K Knoops, ... BioRxiv, 2021.05. 03.441080, 2021 | 11 | 2021 |
Homologous and heterologous serological response to the N‐terminal domain of SARS‐CoV‐2 in humans and mice H Lv, OTY Tsang, RTY So, Y Wang, M Yuan, H Liu, GK Yip, QW Teo, Y Lin, ... European Journal of Immunology 51 (9), 2296-2305, 2021 | 6 | 2021 |
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase R Lei, W Kim, H Lv, Z Mou, MJ Scherm, AJ Schmitz, JS Turner, TJC Tan, ... Immunity 56 (11), 2621-2634. e6, 2023 | 5 | 2023 |
An explainable language model for antibody specificity prediction using curated influenza hemagglutinin antibodies Y Wang, H Lv, R Lei, YH Yeung, IR Shen, D Choi, QW Teo, TJC Tan, ... bioRxiv, 2023 | 5 | 2023 |
Prevalence and mechanisms of evolutionary contingency in human influenza H3N2 neuraminidase R Lei, TJC Tan, A Hernandez Garcia, Y Wang, M Diefenbacher, C Teo, ... Nature communications 13 (1), 6443, 2022 | 4 | 2022 |
Contrasting roles of MERS-CoV and SARS-CoV-2 internal proteins in pathogenesis in mice LYR Wong, A Odle, E Luhmann, DC Wu, Y Wang, QW Teo, C Ptak, ... Mbio 14 (6), e02476-23, 2023 | 1 | 2023 |
Deep mutational scanning of influenza A virus NEP reveals pleiotropic mutations in its N-terminal domain QW Teo, Y Wang, H Lv, KJ Mao, TJC Tan, YW Huan, J Rivera-Cardona, ... bioRxiv, 2024.05. 16.594574, 2024 | | 2024 |
Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza HA stem QW Teo, Y Wang, H Lv, TJC Tan, R Lei, KJ Mao, NC Wu Cell reports 42 (11), 2023 | | 2023 |